How much will Social Security benefits go up next year? Here’s when you’ll know
Rising inflation means Social Security recipients could get their highest cost-of-living adjustment, or COLA, since 2023. They’ll have to wait a while longer, however, to find out exactly how much their checks will increase.
Social Security’s COLA is determined by the Consumer Price Index for Urban Wage Earners and Clerical Workers,
» Read more about: How much will Social Security benefits go up next year? Here’s when you’ll know »
Read MoreDow Jones| Nasdaq | US Stock Market Today | Live: Nasdaq futures slide as AI concerns mount ahead of Big Tech earnings
Dow Jones| Nasdaq | US Stock Market Today | Live: Nasdaq futures slide over 1% as AI, China concerns weigh ahead of Big Tech earnings
Nasdaq futures fell more than 1% on Tuesday, reflecting growing investor caution toward AI and semiconductor stocks ahead of a crucial week of Big Tech earnings.
Read MoreWill Helios Be the Catalyst AMD's Stock Needs to Hit a $1 Trillion Market Cap in 2026?
NASDAQ Index, SP500, Dow Jones Forecasts – NASDAQ Soars As Microsoft Skyrockets 17%
It should be noted that the market expects that Fed will raise rates at the meeting in September. FedWatch Tool indicates that there is a 63.4% probability of a rate hike at the next meeting.
Today, traders also focused on the GDP Growth Rate report. The report indicated that GDP Growth Rate was +1.5% in the second quarter,
Read MoreThe Burst
Is This Heavily Shorted Stock Set To Squeeze Bears?
Despite succeeding in the rough and tumble world of HR management, one particular firm has also become one of the most heavily shorted stocks in the market.
Yet beneath the surface, there are signals that the stock could be on the verge of a sharp rebound—perhaps even a short squeeze that will catch many off guard.
» Read more about: Is This Heavily Shorted Stock Set To Squeeze Bears? »
Read MoreThe Ivy
This AI-Powered Sports Stock That Just Scored Big, Is It a Buy?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock to watch after soaring post earnings despite announcing mixed results for earnings versus revenue for Q4 of 2024.
The company surpassed consensus EPS estimates just once in the past four quarters but revenues have steadily increased and eclipsed consensus expectations.
» Read more about: This AI-Powered Sports Stock That Just Scored Big, Is It a Buy? »
Read MoreThe Spotlight
Spotlight: 1 Heart Transplant Stock Up Over 500%
TransMedics (NASDAQ:TMDX) has emerged as a prominent player in the medical field, witnessing a remarkable surge from $14 to $90 in a little over 18 months.
The company’s core expertise lies in organ care systems, which preserve transplant organs post-donor retrieval.